Synergy Health plc Annual Report & Financial Statements 2011 3 Chairmans statement Our focus on outsourced sterilisation services to the medicaldevice and healthcare industries is serving the business well 2011 has been a good year for Synergy Health, continuing the The Board is proposing a final dividend of 9.84p, which together with improvement in operating performance and at the same time making the interim dividend of 6.00p would give dividends for the year totalling incremental progress towards our strategy of becoming a leading 15.84p 2010: 13.2p representing a 20% increase.
Ifapproved, the global provider of outsourced sterilisation and other niche services.
dividend will be paid on 6 September 2011 toshareholders on the Despite the markets in Europe and the UK remaining challenging register at 12 August 2011. dueto restrained public expenditure, our business has performed wellwith good underlying growth in each of our regions.
Employees To ensure the long term sustainability of the business we have Reported revenues for the period were 287.3 million 2010: 286.4 continued to invest in our teams with the expansion of our talent million.
Underlying revenue growth, after currency effects and the management programme.
Our ability to support the growth of our removal of non-core businesses, was 4.1%.
Adjusted operating business through internal appointments is being greatly enhanced margins were up by 1.1% to 15.0% 2010: 13.9% resulting in bythe evolution of our graduate programme, increased investment profitbefore tax, amortisation and non-recurring items increasing infront line management programmes, and the development of our by17.3% to 38.3 million 2010: 32.6 million.
We are also taking steps to improve the In late 2010 we won a court case in respect of a fire at our Dunstable attractiveness of Synergy to new recruits from a broader range of the linen operation in 2007 resulting in an exceptional pre-tax gain of 5.6 community, with a clear and well executed diversity strategy.
In addition, two acquisitions were undertaken and the costs of The Board continues to be impressed with the efforts and these were expensed asnon-recurring items.
After taking account of commitment of our teams and this is very much reflected in the amortisation and non-recurring items, profit before tax increased by improved operating and financial performance that we have achieved 49.7% to 36.7 million 2010: 24.5 million.
We would also like to welcome our new colleagues As part of a strategy to continue to expand our international network, from GSP in Germany and from BeamOne in the USA and Costa Rica.
during the year we acquired Gamma Service Produktbestrahlung On behalf of the Board, I would like to thank all of our employees for GmbH GSP, a gamma and electron beam sterilisation business their continued dedication and their achievements during the year.
We took a further step just after the year end with the acquisition of BeamOne LLC BeamOne in the USA, making Synergy Outlook thesecond largest global provider of outsourced sterilisation services.
Our underlying growth rate is progressing, supported by our strategy Both businesses have been integrated successfully and are performing tofurther internationalise the business.
In Europe and the UK we are ahead ofexpectations.
not anticipating any significant change in the economic environment and as a result we expect to see a similar trading performance in the The acquisitions were funded from operating cash flow, enabling us to current financial year, whilst in Asia and the Americas we continue retain a strong balance sheet at the year end.
Net debt has reduced by tosee much stronger growth.
21.1 million to 112.3 million 2010: 133.4 million but remained similar to last years net debt position after taking into account the Our focus on outsourced sterilisation services to the medical device BeamOne acquisition completed on the 7 April 2011.
We will shortly and healthcare industries is serving the business well, with the new be completing new unsecured five year revolving credit facilities, to financial year having started strongly.
We anticipate a similarly strong replace the existing facility which is due to mature in January 2012. performance in this new financial year.
During the year, new contracts and contract renewals of 114 million have been achieved, increasing the forward order book to 920 million.
EPS and dividend Adjusted basic earnings per share before amortisation of acquired intangibles and non-recurring items were 53.54p 2010: 45.74p, Robert E Lerwill anincrease of 17.1%.
After taking account of amortisation and Chairman non-recurring items, basic earnings per share were 52.10p 7 June 2011 2010:40.56p, an increase of 28.5%.
Financials Governance Operating and financial review Our strategy Who we are
